BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2025.
World J Diabetes. Oct 15, 2025; 16(10): 110406
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.110406
Table 2 Univariate logistic regression analysis of metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus patients
Variables
β
SE
Z
P value
OR (95%CI)
Sex (female)-0.230.16-1.40.1620.80 (0.58-1.10)
Smoking0.180.161.160.2441.20 (0.88-1.64)
Drinking0.520.163.33< 0.0011.69 (1.24-2.30)
Hypertension0.20.151.30.1931.22 (0.90-1.65)
CAD-0.670.26-2.570.010.51 (0.31-0.85)
Age (years)-0.040.01-6.49< 0.0010.96 (0.95-0.97)
BMI (kg/m2)0.240.038.58< 0.0011.27 (1.20-1.34)
SBP (mmHg)0.0101.850.0641.01 (1.00-1.02)
DBP (mmHg)0.050.016.46< 0.0011.05 (1.03-1.07)
HbA1c (%)0.010.030.210.8341.01 (0.94-1.08)
WBC (× 109/L)0.180.053.64< 0.0011.20 (1.09-1.32)
RBC (× 1012/L)-0.010.02-0.910.3610.99 (0.95-1.02)
PLT (× 109/L)001.730.0841.00 (1.00-1.01)
TP (g/L)0.030.012.250.0241.03 (1.01-1.06)
ALT (U/L)0.0204.69< 0.0011.02 (1.01-1.03)
AST (U/L)0.020.013.030.0021.02 (1.01-1.03)
BUN (mmol/L)-0.190.04-4.86< 0.0010.83 (0.77-0.89)
Scr (mmol/L)00-1.150.251.00 (0.99-1.00)
UA (mmol/L)0.0104.74< 0.0011.01 (1.01-1.01)
TC (mmol/L)0.160.062.650.0081.17 (1.04-1.32)
TG (mmol/L)0.30.055.55< 0.0011.35 (1.21-1.49)
HDL-C (mmol/L)-1.020.29-3.52< 0.0010.36 (0.20-0.64)
LDL-C (mmol/L)0.250.082.960.0031.28 (1.09-1.52)
FBG (mmol/L)00.020.170.8631.00 (0.97-1.04)
ZJU index0.110.017.78< 0.0011.11 (1.08-1.14)


Write to the Help Desk